Feladilimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Feladilimab Usage And Synthesis

Uses

Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has the potential for the research of cancer[1].

References

[1] Offidani M, et al. Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety. Drug Des Devel Ther. 2021 Jun 2;15:2401-2415. DOI:10.2147/DDDT.S267404
[2] Steeghs N, et al. Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development. Clin Transl Sci. 2022 Nov;15(11):2625-2639. DOI:10.1111/cts.13387

Feladilimab(2252518-85-5)Related Product Information

• Zenocutuzumab
• Quetmolimab
• Immunoglobulin G4,anti-(human CD4 (antigen)) (human-mouse monoclonal OKTcdr4a complementarydetermining region-grafted g4-chain), disulfide with human-mouse monoclonal OKTcdr4a complementarydetermining region-grafted k-chain, dimer (9CI)
• Tafolecimab
• Anatumomab
• Lomtegovimab
• Fidasimtamab
• Lutikizumab
• Placulumab
• Garadacimab